Search

everythinglearnresearchcommunity

for

Search:↓

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

PCOS is a common and costly condition in North American women, causing various health issues like obesity, diabetes, and fertility problems.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

Angelica sinensis and Tetrapanax papyrifer are common in Taiwanese TCM for lactation, with potential anticancer benefits.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Examining more lymph nodes can improve survival rates in breast cancer patients without lymph node involvement.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

PEH in vulvar LS is common and needs careful diagnosis to avoid confusion with cancer.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.